Introduction
The omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA), eicosapentaenoic acid (EPA; 20:5n-3), docosahexaenoic acid (DHA; 22:6n-3) and, to some extent, docosapentaenoic acid (DPA; 22:5n-3), are widely regarded as being beneficial to human health and development, being key to neural function as well as in reducing the incidence of chronic pathologies including cardiovascular and inflammatory diseases and cancer among others [1, 2] . However, humans are inefficient at endogenously producing sufficient quantities of n-3 LC-PUFA and therefore require these beneficial fatty acids in the diet [1] . The main dietary sources of these fatty acids are from fish and seafood, but especially oily fish such as mackerel, sardines and salmon [3, 4] . Consequently, global health authorities advocate consuming two portions of fish per week, of which one should be oily, as part of a healthy diet in order to obtain a daily dose of 250-1000 mg EPA+DHA [5] . Nevertheless, the majority of the western world fails to adhere to these guidelines, resulting in low EPA+DHA blood levels that are considered likely to increase the risk of chronic disease [6] .
Nutritional supplements are an effective approach for consumers wanting to increase their dietary nutrient intake, and account for 13% of the global market share for EPA/DHA packaged products, excluding fish, behind infant formula and fortified foods [7] . Of these, encapsulated fish oil products are the most popular form of supplement and are widely available throughout developed countries in either natural or concentrated forms. Despite the majority of commercially available fish oil products meeting or exceeding manufacturers' specifications, many studies have reported the EPA and/or DHA content of some products analysed to be lower than that stated on the label, although there is some disagreement as to what is deemed as being reasonably accurate to the label claim [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Opinions vary as to the exact cause for the missing ccep t e d A Arti cle 5 EPA and/or DHA contents with autoxidation considered to be the most likely factor.
However, the integrity of the analytical techniques employed and the results obtained in some of these studies, most notably Albert et al. [9] , has also been disputed with recommendations that laboratories use standardised and/or accredited methods pertinent to the matrix being tested, together with the validation of methods through regular participation in inter-laboratory proficiency tests [16, 21, 25] .
Marine oils are particularly susceptible to oxidative damage, more than other oils, due to their high number of double bonds, and position within the fatty acid chain, as a consequence of their favourable PUFA content [26] . Lipid oxidation results in the formation of free radicals and lipid hydroperoxides that may undergo further reaction into secondary oxidation products such as aldehydes, ketones and alcohols.
Consequently, the oxidative status of oils can be evaluated through several methods such as measuring the peroxide value (PV) and para-anisidine value (p-AV), among others, as primary and secondary oxidative products, respectively. Industry regulators, including the British and European Pharmacopeias, have limits for n-3 LC-PUFAcontaining oils at 10 meq.kg -1 for PV, 30 for p-AV and 50 for the total oxidation value (TOTOX), a combination of both PV and p-AV to give an assessment of total oxidation [27, 28] . The Global Organization for EPA and DHA omega-3s (GOED), on the other hand, an industry association body commonly representing fish oil manufacturers, have set their own more stringent limits for n-3 LC-PUFA oils, through a Voluntary Monograph of 5 meq.kg -1 , 20 and 26 for PV, p-AV and TOTOX, respectively, as a means of maintaining products of high quality [28, 29] .
Encapsulating marine oils is one method of improving the oxidative stability of n-3
LC-PUFA marine oils [26] . Nevertheless, some studies have reported that the oxidative stability of some encapsulated marine oil products may be of concern with regards to ccep t e d A Arti cle 6 quality and/or safety [9] [10] [11] [12] [13] [14] [15] [30] [31] [32] . In particular, there has been some controversy over the high levels of oxidation found in n-3 LC-PUFA oils from Australia and New
Zealand reported by Albert et al. [9] with suggestions that assay interferences due to the types of oils tested together with the methodologies used may have resulted in false positive results [16, 21, 28] . Nevertheless, the monitoring of fish oil products on the market is of importance in ensuring that products are of a high quality and contain the specified contents to the final consumer.
Thus, the present study looked at the lipid and fatty acid composition, particularly with respect to EPA and DHA in relation to labelled content, as well as the oxidative status, of encapsulated fish oil products available in the UK and discussed how they compare to regulatory guidelines.
Materials and Methods

Sample collection and preparation
Twenty-three encapsulated n-3 LC-PUFA products, consisting of branded and ownbrand standard fish oil and/or fish oil concentrates, were purchased from a variety of retailers and health outlets during January 2017 (see Table 1 The absorbance (A1) was measured at 350 nm against a reference blank of 5 ml isohexane containing 1 ml glacial acetic acid. A reagent solution comprising 1 ml 0.25% para-anisidine in glacial acetic acid was added to the sample and left for 10 min in the dark to react. The absorbance (A2) was measured against 5 ml isohexane containing 1 ml 0.25% para-anisidine in glacial acetic acid and p-AV calculated as: p-
, where W is the oil mass (g).
The total oxidation (TOTOX) value was derived using the results from the PV and p-AV analysis, calculated as TOTOX = 2 x PV + p-AV. 
Statistical tests
Relationships between variables (e.g. oxidative parameters and days to expiry) were assessed using Pearson's correlation coefficient (r). Runs test was used to check linearity with failed data indicating a non-linear relationship (GraphPad Instat® v 3.01). A significance of P<0.05 was applied to all tests.
Results and discussion
Oil capsule content
Overall, the oil capsule content of the 23 analysed sample products was found to be relatively consistent with that declared on the product label (Table 1) . Only sample 7 contained noticeably less than the manufactures stated level (91.4% of the labelled capsule oil content), whereas samples 11 and 13 were found to be in excess of the advertised capsule oil content (117.1 and 118.9%, respectively) ( Figure 1 ). This finding is similar to that of Albert et al. [9] and Kolanowski [11] who reported an oil capsule content range of 95.6-114.2% and 97.2-101.8% respectively, relative to the product label. Nevertheless, although the oil capsule contents in the present study were >90%
ccep t e d
A Arti cle 12 of the manufacturers claimed content such discrepancies will invariably affect the overall fatty acid content (mg.capsule -1 ) delivered to the consumer.
Lipid class and fatty acid composition
Lipid class compositions of oil from capsules analysed in the present study revealed three different types of oil products, consisting mainly of triacylglycerol (TAG), ethyl ester (EE) or a combination of both (Table 2 ). This reflects the wide range of n-3 supplements available on the market in either natural TAG or concentrated forms of fatty acids, particularly with respect to n-3 LC-PUFA content. (Table 3 ).
In contrast, samples 21-23 were fish oil concentrates with highly elevated levels of n-3 LC-PUFA (47.5-85.6%) with EPA+DHA levels of 38.0-75.2% of total fatty acids and EE as the predominant lipid class (94.6-98.0%). The EEs are chemically produced by trans-esterification of TAG fish oils with ethanol, which allows for the subsequent selective concentration of n-3 LC-PUFA, especially EPA and DHA, to levels greater than that found in natural fish oils [41] . However, the bioavailability and uptake of n-3 LC-PUFA as EEs compared to TAG is widely contested, with greater bioavailability suggested for TAG [42] . Although product packaging may specify that supplements are fish oil concentrates, therefore containing higher amounts of EPA and DHA, the oil form is rarely listed. Concentrated EE forms of EPA and DHA may be re-esterified back to TAG, although the conversion process inevitably increases the cost of the final product and, as such, many concentrates are left in the form of EE as observed in the [18, 20, 23] , Brazil [10] and Australasia [17, 19, 21, 43] . The origin of the oils can be further differentiated by their fatty acid profiles using marker fatty acids (Table 3 ). For example, northern hemisphere fish oils tend to exhibit higher levels of gondoic; (20:1n-9) and cetoleic (22:1n-11) acids, associated with the consumption of calanoid copepods by high-latitude zooplanktonivorous fish [44] , as well as lower total monoene levels, and EPA:DHA ratios of around 1.0 [4] . Thus, profiles of samples 1-5, 7-9 and 17-19 all suggest that these products contained northern hemisphere fish oils. Indeed, these samples had cod liver oil as either a component or sole oil source (Table 1) . However, Oenothera biennis, which is characterized by high levels of these fatty acids and has been used to treat systemic disease marked by chronic inflammation, although its efficacy remains disputed [45, 46] . Fish oil capsules, nevertheless, are primarily consumed for their health benefits related to their n-3 LC-PUFA content, specifically EPA and DHA.
EPA and DHA content
Of the 23 capsule products analysed, 12 were found to contain lower EPA+DHA levels than the content stipulated on the product packaging when the expected oil content value was used ( Figure 2 ). However, this was reduced to 11 products when the actual oil capsule content measured was taken into account, with sample 13 increasing from 94.2 to 112.0% of the labelled EPA+DHA content due to a higher than expected capsule oil content (refer to 
Oxidative status of encapsulated oils
In addition to the lower than claimed EPA+DHA levels, several studies have also suggested that the oxidised content of marine oil supplements to be at a level that may be of concern with regards to quality [9-15,30- [28, 29] . This is similar to the 28% noncompliance reported by Bannenberg et al. [16] , but far fewer than the 83% found by Albert et al [9] , who analysed 47 and 36 fish oil products from the Australasian market, respectively. Limits used in the GOED Voluntary Monograph have been voluntarily set by the fish oil manufacturers themselves, and are generally stricter than pharmacopeial standards and regulations to ensure finished fish oil products are of a high quality [28, 29] . However, the high non-compliance rate reported by Albert et al. [9] has been challenged by others with particular criticism directed towards the analytical methods and types of fish oil products tested [16, 21, 25, 28] . Similarly, follow-up studies found Australasian fish oil products to have a greater compliance, in terms of EPA+DHA and oxidation status, than previously reported [16, 21, 24, 28] .
Many of the samples analysed by Albert et al. [9] for example contained flavourings, Moreover, Bannenberg et al. [16] re-examined the oxidative status and EPA and DHA contents of fish oil products one year after they had originally been tested and had passed their expiry dates and found that, although both PV and p-AV had increased, respectively [28, 58] . Nevertheless, although all oils in the current study exhibited no major signs of oxidation through standard analytical techniques it is unclear whether any other signs of oxidation had occurred, which could contribute to fatty acid losses.
The encapsulation of marine oils together with the addition of antioxidants such as tocopherols (vitamin E) are commonly employed to stabilize n-3 oils [26] . However, exposure to air such as during the preparation of oils prior to analysis renders these processes ineffective. Thus, Bannenberg et al [16] suggest that the PV/p-AV ratio should be below 1 as an indicator of good analytical techniques, which was evident in the current study with PV/p-AV ranging from 0.11-0.96 (Table 4) , as a PV/p-AV ratio >1 may indicate that oxidation, specifically primary oxidation, has occurred shortly before analysis due to a prolonged period of air exposure. Irrespective, even under normal storage conditions oxidation will still slowly occur. Accordingly, as in the study of Halvorsen and Blomhoff [30] , but in contrast to Albert et al. [9] , a significant negative relationship was observed between number of days until expiry and PV (r = -0.6264, P = 0.001) as well as for the PV/p-AV ratio (r = -0.5832, P = 0.004) ( Figure   3 ). The number of days before expiry varied greatly between products from 122 to 974 days, indicating the long shelf life of encapsulated fish oil products. This extended shelf life also presents a significant challenge in addressing potential variations between ccep t e d A Arti cle 20 product batches, both with regards to oxidation and fatty acid contents, with products with identical batch numbers being found in multiple stores/retailers regardless of branded or own-brand labels. Consequently, this often restricts studies to single-point analyses on products being tested as in the case of the present study. Nevertheless, collectively these results showed that, although encapsulated fish oil products undergo some form of oxidation during storage, they have the capacity to remain within acceptable levels during the course of their shelf life.
Conclusion
In summary, the present study showed that encapsulated fish oil products obtainable in the UK are available in TAG, EE or TAG/EE forms, which predominantly determine the levels of n-3 LC-PUFA offered to the consumer. Moreover, although some products may fall slightly short of the EPA+DHA contents stated on product labels they are, on the whole, compliant with local regulatory guidelines regarding labelling.
Nevertheless, it is important that studies verify the actual oil capsule content when determining EPA+DHA contents to ensure an accurate representation of levels available to consumers. Similarly, all products tested were below oxidation limits set out for fish oils by pharmacopeial standards, with only a few samples exceeding the stricter industry imposed limits for PV. Further monitoring studies of this nature are merited as an effective way of maintaining quality control and ensuring products adhere to codes of standards.
Conflict of interest
The authors declare no conflicts of interest. 
